Literature DB >> 35459978

In Vitro Testing of Sunscreens for Dermal Absorption: Method Comparison and Rank Order Correlation with In Vivo Absorption.

Yang Yang1, Ann-Marie Ako-Adounvo2, Jiang Wang2, Sergio G Coelho3, Steven A Adah3, Murali K Matta4, David Strauss4, Theresa M Michele3, Jian Wang5, Patrick J Faustino2, Thomas O'Connor2, Muhammad Ashraf2.   

Abstract

Evaluating the dermal absorption of sunscreen UV filters requires the development of a bio-predictable in vitro permeation test (IVPT). This work describes the comparison of two IVPT methods and rank order correlations of in vitro absorption (skin permeation and retention) with the in vivo absorption (AUC and skin retention) of sunscreens. The IVPT was compared regarding the following elements: (1) application of a single finite dose vs. an infinite dose and (2) the use of heat-separated human epidermis vs. dermatomed skin models. The IVPT was used to evaluate dermal absorption of six UV filters (avobenzone, homosalate, octinoxate, octisalate, octocrylene, and oxybenzone) in commercial sunscreens. Both the in vivo and in vitro permeation studies demonstrated that all UV filters were absorbed following a single-dose application. Sunscreens were rank ordered by the amount of the UV filters absorbed. Data obtained from the IVPT method using a single finite dose and heat-separated human epidermis was found to correlate with the clinical data. Rank orders of the cumulative in vitro skin permeation and the in vivo AUC were found comparable for oxybenzone, homosalate, octisalate, and octinoxate. Rank orders of the in vitro and in vivo skin retention of oxybenzone and octinoxate were also comparable. Additional IVPT parameters may be optimized to enhance the discriminatory power for UV filters with low skin permeation potential (e.g., avobenzone and octocrylene).
© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  UV filters; absorption; clinical; skin permeation; sunscreen

Mesh:

Substances:

Year:  2022        PMID: 35459978     DOI: 10.1208/s12249-022-02275-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  14 in total

1.  In Vitro Testing of Sunscreens for Dermal Absorption: A Platform for Product Selection for Maximal Usage Clinical Trials.

Authors:  Yang Yang; Ann-Marie Ako-Adounvo; Jiang Wang; Jinhui Zhang; Daniel Willett; Huzeyfe Yilmaz; Maxwell Korang-Yeboah; Hao-Jui Hsu; Jian Wang; Sergio G Coelho; Steven A Adah; Theresa M Michele; Patrick J Faustino; Celia N Cruz; Sau Lee; Muhammad Ashraf
Journal:  J Invest Dermatol       Date:  2020-04-28       Impact factor: 8.551

2.  Metabolism of UV-filter benzophenone-3 by rat and human liver microsomes and its effect on endocrine-disrupting activity.

Authors:  Yoko Watanabe; Hiroyuki Kojima; Shinji Takeuchi; Naoto Uramaru; Seigo Sanoh; Kazumi Sugihara; Shigeyuki Kitamura; Shigeru Ohta
Journal:  Toxicol Appl Pharmacol       Date:  2014-12-17       Impact factor: 4.219

3.  Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.

Authors:  Murali K Matta; Robbert Zusterzeel; Nageswara R Pilli; Vikram Patel; Donna A Volpe; Jeffry Florian; Luke Oh; Edward Bashaw; Issam Zineh; Carlos Sanabria; Sarah Kemp; Anthony Godfrey; Steven Adah; Sergio Coelho; Jian Wang; Lesley-Anne Furlong; Charles Ganley; Theresa Michele; David G Strauss
Journal:  JAMA       Date:  2019-06-04       Impact factor: 56.272

4.  The UV-filter benzophenone-1 inhibits 17beta-hydroxysteroid dehydrogenase type 3: Virtual screening as a strategy to identify potential endocrine disrupting chemicals.

Authors:  Lyubomir G Nashev; Daniela Schuster; Christian Laggner; Seloni Sodha; Thierry Langer; Gerhard Wolber; Alex Odermatt
Journal:  Biochem Pharmacol       Date:  2009-12-11       Impact factor: 5.858

5.  Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans.

Authors:  Nadeem Rezaq Janjua; Brian Mogensen; Anna-Maria Andersson; Jørgen Holm Petersen; Mette Henriksen; Niels E Skakkebaek; Hans Christian Wulf
Journal:  J Invest Dermatol       Date:  2004-07       Impact factor: 8.551

6.  Heat-separation of normal human skin for epidermal and dermal prostaglandin analysis.

Authors:  V Kassis; J Søndergaard
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

7.  Sunscreens in human plasma and urine after repeated whole-body topical application.

Authors:  N R Janjua; B Kongshoj; A-M Andersson; H C Wulf
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-01-23       Impact factor: 6.166

8.  Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.

Authors:  Murali K Matta; Jeffry Florian; Robbert Zusterzeel; Nageswara R Pilli; Vikram Patel; Donna A Volpe; Yang Yang; Luke Oh; Edward Bashaw; Issam Zineh; Carlos Sanabria; Sarah Kemp; Anthony Godfrey; Steven Adah; Sergio Coelho; Jian Wang; Lesley-Anne Furlong; Charles Ganley; Theresa Michele; David G Strauss
Journal:  JAMA       Date:  2020-01-21       Impact factor: 56.272

9.  Systemic Absorption of Sunscreen: Balancing Benefits With Unknown Harms.

Authors:  Adewole S Adamson; Kanade Shinkai
Journal:  JAMA       Date:  2020-01-21       Impact factor: 56.272

10.  Concentrations of the sunscreen agent benzophenone-3 in residents of the United States: National Health and Nutrition Examination Survey 2003--2004.

Authors:  Antonia M Calafat; Lee-Yang Wong; Xiaoyun Ye; John A Reidy; Larry L Needham
Journal:  Environ Health Perspect       Date:  2008-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.